We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$132M
AUM Growth
-$1M
Cap. Flow
-$50.9M
Cap. Flow %
-38.52%
Top 10 Hldgs %
64.22%
Holding
198
New
26
Increased
36
Reduced
14
Closed
106

Sector Composition

Rank Sector Weight
1 Technology 11.19%
2 Healthcare 3.67%
3 Industrials 1.57%
4 Consumer Discretionary 0.76%
5 Communication Services 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGX icon
51
Argan
AGX
$6.9B
$197K 0.15%
+5,211
New +$220K
VVUS
52
DELISTED
Vivus Inc
VVUS
$111K 0.08%
50,292
+20,292
+68% +$69.9K
ACHV icon
53
Achieve Life Sciences
ACHV
$634M
$108K 0.08%
4,482
+2,882
+180% +$109K
XLU icon
54
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
$107K 0.08%
4,084
+1,678
+70% +$45.6K
CZR
55
PUT
DELISTED
Caesars Entertainment Corporation
CZR
$99K 0.07%
+73,800
New +$622K
AXSM icon
56
Axsome Therapeutics
AXSM
$11.7B
$96K 0.07%
34,448
-5,552
-14% -$18.3K
XLRE icon
57
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
$91K 0.07%
2,948
+719
+32% +$23.3K
IMMU
58
PUT
DELISTED
Immunomedics Inc
IMMU
$88K 0.07%
+157,100
New +$3.12M
FEED
59
ENvue Medical Inc
FEED
$2.01M
$72K 0.05%
9
ENTX icon
60
Entera Bio
ENTX
$148M
$53K 0.04%
26,947
+14,339
+114% +$71.3K
IEC
61
DELISTED
IEC Electronics Corp.
IEC
$48K 0.04%
+8,800
New +$48K
FOMX
62
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$48K 0.04%
+13,500
New +$58.7K
ATEX icon
63
Anterix
ATEX
$1.72B
$42K 0.03%
+1,128
New +$44.1K
XLE icon
64
State Street Energy Select Sector SPDR ETF
XLE
$39B
$39K 0.03%
1,410
-1,788
-56% -$59.8K
WFT
65
PUT
DELISTED
Weatherford International plc
WFT
$38K 0.03%
39,500
-23,400
-37% -$30.5K
WTT
66
DELISTED
Wireless Telecom Group, Inc.
WTT
$32K 0.02%
18,099
-7,001
-28% -$12.2K
ATNM icon
67
Actinium Pharmaceuticals
ATNM
$26.3M
$22K 0.02%
1,969
-1
-0.1% -$17
KBR icon
68
PUT
KBR
KBR
$4.56B
$20K 0.02%
+44,100
New +$825K
HSTO
69
CALL
DELISTED
Histogen Inc. Common Stock
HSTO
$13K 0.01%
200
+121
+153% +$94K
APHA
70
DELISTED
Aphria Inc. Common Shares
APHA
$12K 0.01%
+2,309
New +$18.2K
GCVRZ
71
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$12K 0.01%
27,035
+22
+0.1% +$11
WFT
72
DELISTED
Weatherford International plc
WFT
$9K 0.01%
+17,000
New +$22.2K
FLNA
73
Filana Therapeutics
FLNA
$42M
$6K ﹤0.01%
+8,178
New +$9.4K
PBYI icon
74
CALL
Puma Biotechnology
PBYI
$398M
$5K ﹤0.01%
+20,000
New +$600K
ICPT
75
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4K ﹤0.01%
700

Similar funds

Worth Venture Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Worth Venture Partners held 198 positions worth $132M, down 0.75% from $133M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Worth Venture Partners withdrew a net $50.9M in Q4 2018, closing 106 positions and reducing 14 holdings. Its most notable exit was NXP Semiconductors, an estimated $3.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Qualcomm worth $3.84M.

  • Worth Venture Partners's largest Q4 2018 buy was Qualcomm: 67,444 shares worth $3.84M.
  • Worth Venture Partners added most to iShares Russell 2000 ETF in Q4 2018, an estimated $1.56M increase.
  • Worth Venture Partners's biggest Q4 2018 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.56M.
  • Worth Venture Partners fully exited NXP Semiconductors in Q4 2018, selling an estimated $3.52M.
  • Worth Venture Partners's ten largest holdings make up 64% of its $132M portfolio in Q4 2018.
  • Worth Venture Partners opened 26 new positions and closed 106 in Q4 2018.
  • Worth Venture Partners's portfolio value fell 0.75% quarter-over-quarter to $132M.

Based on Worth Venture Partners's 13F filing for Q4 2018, filed 15 Feb 2019.